July 16, 2019 – AHI participated in the FDA Center for Veterinary Medicine’s public meeting about alternative approaches in clinical investigations for new animal drugs. The meeting included four sessions that focused on the following topics: (1) complex adaptive and other novel investigation designs; (2) data from foreign countries; (3) real-world evidence; and (4) biomarkers […]
Washington, DC – December 7, 2017 – Antibiotic sales – whether they go up or down – are not predictors of public health impact. While today’s sales report is an interesting piece of the story, we are more encouraged by the recent data from the National Antimicrobial Resistance Monitoring System that shows that for those pathogens that might transfer from animals to humans, resistance rates in people have been stable or declining.
The Animal Health Institute (AHI) represents the companies that develop and produce animal medicines. Our industry is a global leader whose products improve the health of nearly 10 billion companion and food-producing animals in the U.S., which results in significant economic and social benefits for Americans.